Last reviewed · How we verify
NCT02171897: PAVO
Pertrochanter Arthroplasty Versus Osteosynthesis
NA trial testing Osteosynthesis in Pertrochanter Fracture in 70 participants. Completed in 21 October 2018.
21 October 2018
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire Dijon |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Enrollment | 70 |
| Start date | 29 January 2015 |
| Primary completion | 21 October 2018 |
| Estimated completion | 21 October 2018 |
| Sites | 1 location across France |
Drugs / interventions tested
- Osteosynthesis
- Total hip replacement
Conditions studied
- Pertrochanter Fracture — all drugs for Pertrochanter Fracture →
Sponsor
Centre Hospitalier Universitaire Dijon
Who can join
70 and older, any sex, with Pertrochanter Fracture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a single-centre, comparative, prospective randomised trial. It will include 70 patients over a period of 2 years randomized into two groups of 35 patients: one group of patients treated with osteosynthesis (plate, nail or screw) and the second group treated with total hip replacement. The Harris and PMA functional scores will be assessed at 6 weeks, 3 months, 6 months and 1 year. The time to recovery of weight-bearing, the subjective satisfaction score, the EQ5D quality of life questionnaire, the VAS score for pain at rest and when walking, the Parker score, the rate of complications and deaths will also be measured. Operating time, blood loss and scar size will also be evaluated.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Surgical interventions for treating extracapsular hip fractures in older adults: a network meta-analysis.
Lewis SR, Macey R, Lewis J, Stokes J, et al · · 2022 · cited 31× · PMID 35142366 · DOI 10.1002/14651858.cd013405.pub2
Verify or expand the search:
- PubMed search for NCT02171897
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Osteosynthesis
Trials testing the same drug.
- NCT05739240 — Effects of Preoperative 3D Printing of Distal Intra-articular Radius Fractures on Quality of Fracture Reduction · NA · unknown
- NCT05672069 — Ambispective, Multicentre, Open-label Study Evaluating the Clinical Outcomes of Foot Surgery Using SERF Medical Devices · completed
- NCT04668794 — Carpometacarpal Fracture-dislocations · completed
- NCT04217642 — Hip Fracture in Cauca. Cohort Study · unknown
- NCT05325268 — Monteggia Fractures: Analysis of Patient Reported Outcome Measurements in Correlation to Ulnar Fracture Localization · completed
Other Centre Hospitalier Universitaire Dijon trials
Trials by the same sponsor.
- NCT06608004 — Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT06776848 — A Pilot, Multicentre, Controlled, Open-label Study Evaluating 24 Months of Lithium Carbonate Treatment in Patients With · Phase 1, PHASE2 · recruiting
- NCT06347302 — Study of Vitreoretinal Molecular Changes During Rhegmatogenous Retinal Detachment · NA · completed
- NCT06252415 — Evaluation of Rapid First-line Genome Sequencing for Prenatal Diagnosis of Congenital Malformations in Comparison With C · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02171897 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Dijon
- Last refreshed: 4 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02171897.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing